Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)

ClinicalTrials.gov ID: NCT04339413

Public ClinicalTrials.gov record NCT04339413. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 4:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter, Rollover Study to Evaluate the Safety and Tolerability of Long-Term Administration of Gantenerumab in Participants With Alzheimer's Disease

Study identification

NCT ID
NCT04339413
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
116 participants

Conditions and interventions

Interventions

  • Gantenerumab Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 21, 2020
Primary completion
Jan 3, 2023
Completion
Jan 3, 2023
Last update posted
Jan 17, 2024

2020 – 2023

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Banner Sun Health Research Insitute Sun City Arizona 85351
California Neuroscience Research Medical Group, Inc Sherman Oaks California 91403
Accelerated Enrollment Solutions Orlando Florida 32806
University of South Florida Tampa Florida 33612
Bioclinica The Villages The Villages Florida 32162
Western Michigan University Homer Stryker M.D. School of Medicine Center for Clinical Research Kalamazoo Michigan 49008
Richmond Behavioral Associates Staten Island New York 10314
Alzheimer's Memory Center Matthews North Carolina 28105
Central States Research Tulsa Oklahoma 74136
Neurology Clinic PC Cordova Tennessee 38018
Senior Adults Specialty Research Austin Texas 78757

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04339413, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2024 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04339413 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →